Skip to main content
 
Print Page    E-mail Page    RSS    E-mail Alerts    Tearsheet 

Investors & Media

Corporate Profile

Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing a novel class of biological drugs, which we refer to as Ecobiotic microbiome therapeutics, that are designed to restore health by repairing the function of a dysbiotic microbiome. The Company’s lead product candidate, SER-109, is intended to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon, and, if approved by the FDA, could be a first-in-field drug. Using its... More

Recent NewsMore
08/03/17
Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress
... 
08/02/17
Seres Therapeutics to Present at the Canaccord Genuity 37th Annual Growth Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 2, 2017-- Seres Therapeutics, Inc. (NASDAQ:MCRB) today announced it will present at the Canaccord Genuity 37th Annual Growth Conference in Boston, MA on Wednesday, August 9 at 1:00 p.m. ET. A live audio webcast of the presentation will be available under the “Investors and Media” section of Seres’ website. A replay of the presentation will become available approximately one hour after the even... 
07/27/17
Seres Therapeutics to Host Second Quarter 2017 Financial Results and Operational Progress Conference Call and Webcast on August 3, 2017
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul. 27, 2017-- Seres Therapeutics, Inc. (NASDAQ:MCRB) today announced that management will host a conference call and live audio webcast on August 3, 2017 at 8:00 a.m. ET to discuss second quarter 2017 results and provide a general business update. To access the conference call, please dial 844-277-9450 (domestic) or 336-525-7139 (international) and reference the conference ID number 62118608. To join th... 
EventsMore
There are currently no upcoming events scheduled.
Stock Quote
NASDAQ:MCRB
$12.94
 - 0.39 (2.93%)
08/18/17 4:00 p.m. ET
Refresh quote
E-mail Alerts
Sign up to receive e-mail alerts whenever Seres Therapeutics, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
Request Information

Obtain investor relations information by contacting us.

More
Data provided by Nasdaq. Minimum 15 minutes delayed.